The hierarchical development from hematopoietic stem cells to mature cells of the hematolymphoid system involves progressive loss of self-renewal capacity, proliferation ability, and lineage potentials. Here we show the prospective isolation of early developmental intermediates, the human clonogenic common myeloid progenitors and their downstream progeny, the granulocyte͞macrophage and megakaryocyte͞erythrocyte progenitors. All three populations reside in the lineage-negative (lin ؊ ) CD34 ؉ CD38 ؉ fraction of adult bone marrow as well as in cord blood. They are distinguishable by the expression of the IL-3R␣ chain, the receptor of an early-acting hematopoietic cytokine, and CD45RA, an isoform of a phosphotyrosine phosphatase involved in negative regulation of cytokine signaling. Multipotent progenitors, early lymphoid progenitors, and the here-defined myeloid progenitors express distinct profiles of hematopoiesisaffiliated genes. The isolation of highly purified hematopoietic intermediates provides tools to better understand developmental programs underlying normal and leukemic hematopoiesis.
The hierarchical development from hematopoietic stem cells to mature cells of the hematolymphoid system involves progressive loss of self-renewal capacity, proliferation ability, and lineage potentials. Here we show the prospective isolation of early developmental intermediates, the human clonogenic common myeloid progenitors and their downstream progeny, the granulocyte͞macrophage and megakaryocyte͞erythrocyte progenitors. All three populations reside in the lineage-negative (lin ؊ ) CD34 ؉ CD38 ؉ fraction of adult bone marrow as well as in cord blood. They are distinguishable by the expression of the IL-3R␣ chain, the receptor of an early-acting hematopoietic cytokine, and CD45RA, an isoform of a phosphotyrosine phosphatase involved in negative regulation of cytokine signaling. Multipotent progenitors, early lymphoid progenitors, and the here-defined myeloid progenitors express distinct profiles of hematopoiesisaffiliated genes. The isolation of highly purified hematopoietic intermediates provides tools to better understand developmental programs underlying normal and leukemic hematopoiesis. T hroughout life, the hematolymphoid system is regenerated from a small fraction of self-renewing hematopoietic stem cells (HSCs). Most of the knowledge about factors that initiate the maturation process of progenitor cells and induce restriction to one hematopoietic lineage is achieved in principle through two approaches: (i) the observation of natural occurring or artificially induced genetic alterations that lead to characteristic phenotypes, and (ii) the rigorous purification of HSC and͞or progenitor cell populations that are tested at the clonal level for their full developmental capacity and in short-term developmental tests for their placement in a lineage. We recently have isolated by surface phenotype clonogenic common lymphoid progenitors (1) and clonogenic common myeloid progenitors (CMPs) and their myeloid downstream progeny, the granulocyte͞macrophage (GMPs) and megakaryocyte͞erythrocyte progenitors (MEPs) (2) in mouse bone marrow. These findings together with data from other groups indicate that the commitment to either the lymphoid or myeloid lineage and downstream to the granulocyte͞macrophage and megakaryocyte͞erythro-cyte lineages are exclusive events. In humans, multiple reports describe the enrichment of progenitor populations in bone marrow, mobilized peripheral blood, thymus, cord blood, fetal bone marrow, and fetal liver (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) . However, to the best of our knowledge, thus far only early lymphoid lineage-restricted progenitors have been isolated and evaluated rigorously for all their developmental capacity on a clonal basis: An adult human bone marrow lineage-negative (lin
cell gives rise to B, natural killer (NK), and dendritic cells on a clonal level and to T cells at high frequencies (7) , and a cord blood CD34 ϩ CD38 Ϫ CD7 ϩ cell gives rise to B, NK, and dendritic cells (8) , but both are devoid of myeloerythroid differentiation capacity. We therefore searched for distinct early myeloerythroidcommitted progenitors, the human counterparts of the described murine CMPs, GMPs, and MEPs, in adult human bone marrow and cord blood. For analysis and sorting of myeloid progenitors, cells were stained with phycoerythrin (PE)-Cy5-conjugated antibodies specific for lin markers CD3, S4.1; CD4, S3.5; CD7, CD7-6B7; CD8, 3B5; CD10, 5-1B4; CD14, TUK4; CD19, SJ25-C1 (Caltag, South San Francisco, CA); CD2, RPA-2.10; CD11b, ICRF44; CD20, 2H7; CD56, B159; GPA, GA-R2 (Becton Dickinson-PharMingen, San Diego), and FITC-conjugated anti-CD45RA, MEM56 (Caltag), PE-conjugated anti-IL-3R␣, 9F5 (Becton DickinsonPharMingen), biotinylated anti-CD38, HIT2 (Caltag), and APC-conjugated anti-CD34, HPCA-2 (Becton DickinsonPharMingen).
Materials and Methods
Lymphoid progenitors were stained with the same PE-Cy5-conjugated lineage mixture except for the omission of anti-CD7, anti-CD10, and the addition of anti-CD13, TUK1 (Caltag) followed by FITC-conjugated anti-CD10 (Ancell, Bayport, MN), PE-conjugated anti-IL-7R␣ (Immunotech, Marseilles, France), and anti-CD38 and CD34 as described above. For additional analysis FITC-, PE-, Texas red-, or APC-conjugated or biotinylated monoclonal antibodies against the following antigens were used: CD45, HI30; CD13, TUK1; CD16, 3G8; CD71, T56͞14; HLA-DR, TU36 (Caltag); CD3, HIT3a; CD4, RPA-T4, CD8, HIT8a; CD9, M-L13; CD19, HIB19; CD32, FLI8.26; CD33, WM53; CD41a, HIP8; CD45RA, HI100; CD56, B159; CD64, 10.1; CD71, M-A712; CD90, A59; CD117, YB5.B8; Glycophorin A (GPA), HIR2 (Becton Dickinson-PharMingen). Streptavidin-conjugated Texas red or Cy7-PE (GIBCO) was used for visualization of biotinylated antibodies. Dead cells were excluded by propidium iodide staining. Appropriate isotypematched, irrelevant control monoclonal antibodies were used to determine the level of background staining. Cells were sorted and analyzed by using a highly modified dual-laser FACS Vantage (Becton Dickinson Immunocytometry Systems, Mountain View, CA) and a dual-laser MoFlo cytometer (Cytomation, Fort Collins, CO), both equipped with a 488-nm argon laser and a 599-nm dye laser. All cells were double-sorted to obtain populations that were essentially pure for the indicated surfacemarker phenotype. For single-cell and limiting-dilution assays, the re-sort was performed by using an automatic cell-deposition unit (ACDU) system (Becton Dickinson).
In Vitro Assays to Determine Differentiation Potential of Progenitors.
For myeloid colony formation, cells were cultured over 14 days in Iscove's modified Dulbecco's medium (IMDM, GIBCO) based methylcellulose medium (Methocult H4100, StemCell Technologies, Vancouver) supplemented with 20% FBS (lot no. 315853, ICN), 1% BSA, 2 mM L-glutamine, 50 M 2-mercaptoethanol, antibiotics, and human IL-3 (20 ng͞ml), IL-6 (10 ng͞ml), IL-11 (10 ng͞ml), stem cell factor (SCF, 10 ng͞ml), Flt3 ligand͞(FL, 10 ng͞ml), granulocyte͞macrophage colonystimulating factor (50 ng͞ml), thrombopoietin (Tpo, 50 ng͞ml), and erythropoietin (Epo, 4 units͞ml) (all R & D Systems). FBS was selected from multiple sera to obtain significant megakaryocyte development. For short-term liquid cell culture, cells were cultured in IMDM with 10% FBS, IL-11 (10 ng͞ml), SCF (10 ng͞ml), FL (10 ng͞ml), Tpo (50 ng͞ml), and Epo (4 units͞ml).
To support the formation of B and NK cells, progenitors were cultured for 3-5 weeks on irradiated (25 Gy) SyS-1 (Ac6) stromal cell monolayers in IMDM supplemented with 10% FBS (HyClone), SCF (10 ng͞ml), FL (10 ng͞ml), and IL-7 (50 ng͞ml) (for B cell readout) or IL-2 (50 ng͞ml, for NK cell readout), or IL-7 and IL-2 (for combined B and NK cell readout). Half of the medium was replaced weekly.
Long-term culture initiating-cell (LTC-IC) assays were performed in human long-term culture medium (Myelocult H5100, StemCell Technologies) supplemented with hydrocortisone on irradiated M2-10B4 monolayers according to manufacturer instructions. Cells were transferred to the above-described methylcellulose medium after 6 weeks. All cultures were incubated at 37°C in a humidified chamber under 7% CO 2 .
Reverse Transcription-PCR Analysis. Total RNA was purified from 1,000 double-sorted cells from each population and amplified by reverse transcription-PCR as reported (17) . Oligonucleotide primer sequences were as reported previously and can be provided upon request. PCR products were electrophoresed on an ethidium bromide-stained 2.0% agarose gel. PCR analysis was repeated at least twice for at least two separately prepared sets of samples.
Results

Identification of Three Distinct Cell Populations with High Myeloerythroid Colony-Forming Unit (CFU) Activity in Adult Human Bone Marrow.
We first tested myeloid colony-forming potentials in CD34 ϩ and CD34 Ϫ human bone marrow cells and confirmed previous findings that more than 95% of CFUs reside in the CD34 ϩ cell fraction (data not shown). Cells with multipotent, self-renewing hematopoietic capacity are lin Ϫ CD34 ϩ CD38 Ϫ Thy1 ϩ , whereas CD34 ϩ CD38 ϩ cells, the major fraction of all CD34 ϩ cells, are further differentiated and have lost both self-renewing capacity and bipotent lymphomyeloid potential (18) (19) (20) (21) (22) (23) (24) . The coexpression of CD10 or CD7 on CD34 ϩ cells in adult bone marrow or cord blood defines the earliest described clonal human lymphoid-committed progenitors (7, 8) . To exclude multipotent progenitors, lymphoid-restricted progenitors, and more mature lineage low cells, we therefore searched for the earliest myeloidcommitted cells in the lin Ϫ (CD2, CD3, CD4, CD7, CD8, CD10, CD11b, CD14, CD19, CD20, CD56, and GPA) CD34 ϩ CD38 Fig. 1 a and b) . The three populations display relatively uniform levels of the SLF receptor c-Kit (CD117), CD13, CD33, and HLA-DR, but they are negative for Thy-1 (CD90), FcR III (CD16), FcR II (CD32), FcR I (CD64), CD41a, and CD9 ( Fig. 1c and not shown) .
The IL-3R␣
, and IL-3R␣ Ϫ CD45RA Ϫ fractions gave rise to distinct colony types in methylcellulose CFU assays with the indicated cytokines ( Fig. 2 a  and b) . To evaluate cloning efficiency and colony types precisely, single cells of each population from 18-27-year-old donors were sorted in 96-well plates (Fig. 2c) . HSC-enriched lin Fig. 2b . In our culture condition, megakaryocytes were still immature on day 14; a majority displayed only one or two nuclear lobes (Fig. 2b Left) , whereas scattered mature megakaryocytes possessed lobulated polyploid nuclei (Fig. 2b Right Insert) . (Fig. 3a) . Of note, IL-3R␣ and CD45RA expression levels were always higher in cultured cells than in freshly isolated bone marrow cells. In four experiments with different donors, cultured cells were re-sorted on methylcellulose (in total 250 IL-3R␣ lo CD45RA Ϫ cells and 300 GMPs and MEPs each). As with the freshly isolated populations, albeit with lower cloning efficiency, IL-3R␣ lo CD45RA Ϫ cells gave rise to all types of colonies (but CFU-GEMM), GMPs exclusively gave rise to granulocyte͞macrophage colonies, and MEPs gave rise to megakaryocyte͞erythrocyte colonies and four (1.6%) granulocyte and macrophage colonies (Fig. 3b) . Therefore, the IL-3R␣ 
IL-7R␣
ϩ progenitors reliably gave rise to B and NK cells, but from up to 5,000 CMPs, MEPs, or GMPs no B or NK cell readout could be detected (Fig. 4) . However, up to 100 lin Ϫ CD34 ϩ CD38 Ϫ cells tested did not give rise to B or NK cells either, indicating that only lymphoid-committed cells were able to readout into those lineages under the given culture conditions. Therefore, although we cannot exclude a possibility that the myeloid progenitors harbor cells with some lymphoid developmental potential in vivo, none of the three populations contains cells readily committed to the B or NK lineage. (Fig. 5) . The results show expression profiles generally consistent with the distinct in vitro readout capacities of the different progenitors.
Myeloid Progenitors Have Limited or
Whereas granulocyte colony-stimulating factor receptor, C͞EBP, and MPO were expressed by GMPs and not by MEPs, GATA-1, EpoR, c-mpl, ␤-globin, and von Willebrand factor were detected in MEPs but not in GMPs. Interestingly, some gene transcripts such as PU.1, MPO, and GATA-1 were detectable in HSC-enriched CD34 ϩ CD38 Ϫ cells. It shall be important to test whether these transcripts result in protein production that is involved in cell fate decision at this early developmental stage. It shall also be important to determine whether these transcripts are present in lin
HSC or in Thy1
Ϫ progenitors (17) . Of note, none of the myeloid progenitors expressed detectable levels of genes relevant in lymphoid development as TdT, GATA-3, preT␣, IL-7R␣, and Pax-5, which were expressed in the lymphoid-committed lin
Therefore, the gene-expression profile supports the exclusive separation of the lymphoid and myeloid and further the downstream granulocyte͞macrophage and megakaryocyte͞erythrocyte developmental pathway.
CMPs, GMPs, and MEPs Can Be Isolated from Cord Blood. Two cord blood samples were evaluated for the above surface-marker expression, and 100 cells of each population were tested for 5 . Differential mRNA expression of hematopoiesis-affiliated genes in primitive progenitors (CD34 ϩ CD38 Ϫ ), myeloid-committed progenitors, and lymphoid-committed progenitors. Total CD34 ϩ bone marrow cells were used as controls. GM-CSFR, granulocyte͞macrophage colony-stimulating factor receptor; G-CSFR, granulocyte colony-stimulating factor receptor; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; vWG, von Willebrand factor; C͞EBP, CCAAT-enhancer-binding protein ; MPO, myeloperoxidase; EpoR, erythropoietin receptor; TdT, terminal deoxynucleotidyl transferase.
myeloid colony-formation activity. Although the distinct surface-marker expression profile was similar to adult bone marrow, percentages of the myeloid progenitor populations were slightly different: IL-3R␣ lo CD45RA 
Discussion
In this study we dissect by prospective isolation human multipotent hematopoietic progenitor cells from the earliest committed CMPs and further the downstream GMPs from MEPcommitted stages. We directly show that CMPs are clonogenic progenitors of both GMPs and MEPs. The phenotype of these populations does not overlap with that of HSCs, and the defined populations have only very low LTC-IC activity. Furthermore, none of these myeloid progenitors exhibit in vitro differentiation activity for B or NK cells. We did not test the T cell potential of these populations; however, myeloid progenitors express neither early lymphoid markers such as CD7 and CD10 (7, 8) nor IL-7R␣ (not shown), which is expressed in human T cell progenitors and transduces indispensable signals in human T cell development (25) . In two experiments we transplanted 1. The defined myeloid progenitors exhibit distinct surfaceexpression patterns of IL-3R␣ and CD45RA. IL-3 is an early cytokine that supports proliferation and differentiation of HSCs as well as primitive multipotent and myeloid progenitors (27) (28) (29) , whereas the receptor tyrosine phosphatase CD45, and presumably its CD45RA isoform, can negatively regulate at least some classes of cytokine-receptor signaling (30) . Several previous studies have been communicated concerning the surfaceantigen expression of early myeloid progenitor cells in humans (3, 6, (9) (10) (11) (12) . It was shown that CD34 ϩ CD45RA ϩ cells are devoid of erythroid and enriched for granulocyte and macrophage progenitor cells (6, 10) . Also, different levels of IL-3R␣ expression on CD34 ϩ cells reportedly are associated with preferential lineage readout, as IL-3R␣ Ϫ cells are enriched for erythroid, IL-3R␣ lo cells for multipotent, and IL-3R␣ ϩ cells for granulocyte͞macrophage colony-forming cells (9) . However, in those studies early lymphoid cells, lineage low or positive cells, and͞or HSCs and multipotent progenitors within the CD34 ϩ fraction were not excluded by using negative or positive markers, likely resulting in heterogeneous populations. When reported, the populations exhibited relatively low cloning efficiencies (6, 12) or contained multipotent progenitors and HSCs (9) . In our study, the relationship between the expression pattern of CD45RA͞ IL-3R␣ and lineage potentials within the myeloid progenitor fraction is consistent with previous reports. The additional use of a panel of markers enabled us to highly purify lineal populations of CMPs and downstream GMPs and MEPs, which represent developmental checkpoints for erythroid͞megakaryo-cyte versus granulocyte͞macrophage lineages.
It was reported also that CD64 (Fc␥R I)-expressing cells in the human CD34 ϩ bone marrow fraction (Ϸ23% of fetal bone marrow CD34 ϩ cells) contained granulocyte͞macrophage-committed progenitors at a relatively low frequency (cloning efficiency 26-50%; refs. 11 and 12). We could not find CD64 expression on the lin Ϫ CD34 ϩ CD38 ϩ cells by using antibodies from hybridoma clone 10.1, which also were used in these previous studies (11) . The most likely explanation for this finding is that the CD64 ϩ cells were gated out in our study by using CD11b as a lineage marker, because the vast majority of CD64 ϩ cells reportedly coexpress CD11b (11) . Therefore it is possible that the CD64 ϩ progenitors may reside in a lineage low to positive fraction, which is likely to be downstream of GMPs. Indeed, although the progenitor populations described here cover most of the colony-forming cells, we found a low frequency of both erythroid and myeloid colony-forming cells in the CD34 ϩ CD38 ϩ lin ϩ fraction. We propose that most if not all myeloid hematopoiesis is developing through the here-described progenitors; however, we cannot exclude the existence of other, paralleldeveloping, minor progenitor populations that express lineage markers.
In mouse hematopoiesis, CMPs, GMPs and MEPs all are contained in the lin . In contrast, all the human myeloid progenitor populations described here are positive for CD34 and do not express detectable levels of CD16͞CD32. We therefore in turn looked for IL-3R␣ and CD45RA expression on murine myeloid progenitors (2) . Interestingly, in mouse hematopoiesis, IL-3R␣ as well as CD45RA expression both were negative to low in MEPs, intermediate in CMPs, and positive in GMPs, without providing sufficient discrimination to clearly set a cut-off level between the different cellular fractions (not shown). Thus, a number of markers expressed in progenitor or stem cells seem to be differentially regulated in early human and mouse myelopoiesis (31) .
The prospectively purified, lineage-restricted human progenitors at defined myeloid developmental stages shown here should provide tools to study transcriptional regulation as well as the role of intrinsic and͞or extrinsic signals in lineage commitment (32) . Also, common developmental pathways or lineage origins of rare hematopoietic cells such as dendritic cells can be evaluated directly (33, 34) . Finally, these progenitors might be useful in determining stages at which leukemogenic events occur (17, (35) (36) (37) (38) .
